Anti-PDGF Drug Targets Heart of Angiogenesis
By: Pravin U. Dugel, MD
Novel combination AMD therapy yields startlingly good outcomes, a study investigator reports.
Pharmacogenomics and Treatment of Neovascular AMD
By: Alan J. Franklin, MD, PhD; Sunil Gupta, MD; Magdalena Shuler, MD, PhD; John Phillip Myers, MD; Brent Zanke, MD, PhD, FRCPC
How genotype can affect response to treatment
Peripapillary Changes In Pathologic Myopia
By: Kyoko Ohno-Matsui, MD, PhD
Swept-source OCT can help image changes in high myopia.
Avastin in ROP
By: Vishak J. John, MD; Ditte Hess, CRA
The anti-VEGF drug has shown promise in the treatment of retinopathy of prematurity.
Classification of Age-related Macular Degeneration
By: Usha Chakravarthy, MD, FRCS, FRCOphth, PhD
A system is needed that both clinicians and patients can understand.
The Use of Macular Microperimetry in the Assessment and Diagnosis of Macular Disease
By: David Squirrell, Franzco; Rita Ehrlich, MD
The use of microperimetry in retina is developing.
Bilateral Exudative Retinal Detachments
By: Daniel A. Chruscicki, MD; Stephanie Sutton, MS; Elizabeth Sutton, MS
A suspicion of VKH in a patient with a stem cell disorder.
Upfront: From the Editor-in-Chief
By: Peter K. Kaiser, M.D.
Changing vessels
Subspecialty News
By: Jerry Helzner, Senior Editor
Integrin peptides: a new type of anti-VEGF; Patients benefit from remote DR screening; Triesence effective for macular edema;
Allergan commits to DARP in research; and more
SURGICAL PRECISION
By: Steve Charles, MD, FACS, FICS
Intricacies of the Use of Perfluorocarbon Liquids
CODING Q&A
Intravitreal injections: Making sure your claims are approved
Can Anti-VEGF Trigger GA?
By: Jerry Helzner, Senior Editor
The issue is spurring a lively debate.